{"product_id":"harvard-medical-school-diabetes","title":"Harvard Medical School Diabetes Update 2023","description":"\u003ch2\u003e\u003cspan style=\"color: #1b1919; font-size: 24px;\"\u003eThe Harvard Medical School Diabetes Update 2023\u003c\/span\u003e\u003c\/h2\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cem\u003eDiabetes Update will be held online this year, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies. \u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eEDUCATION to MEET THE CHALLENGES of DIABETES CARE\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAt a time when our diabetes knowledge and treatment options have advanced so much, why do clinical outcomes remain suboptimal, with so many patients unable to achieve good control of their disease?\u003cbr\u003e\u003cbr\u003eThe answer is rooted in four challenges:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eKeeping pace with rapidly advancing clinical options for diabetes care:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eTherapies\u003c\/li\u003e\n\u003cli\u003eTechnologies\u003c\/li\u003e\n\u003cli\u003eLifestyle medicine interventions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eDesigning comprehensive therapeutic interventions based on frequent diabetes-associated diseases and complications\u003c\/li\u003e\n\u003cli\u003eAccounting for a patient’s unique biological, psychological, social, financial, educational, and cultural factors\u003c\/li\u003e\n\u003cli\u003eOvercoming structural healthcare barriers that require clinical strategies to fit within a particular mold\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThis course is designed to equip clinicians to meet these challenges, providing practical, evidence-based approaches to optimize care for your patients.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eSTRATEGIES, UPDATES, and BEST PRACTICES for STATE-OF-THE-ART DIABETES CARE\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.\u003cbr\u003e\u003cbr\u003eParticipants can rely on this program for comprehensive education to ensure state-of-the-art treatment. Coverage includes:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDesign of more effective treatment plans\u003c\/li\u003e\n\u003cli\u003eCurrent anti-diabetes medications and how to use them\u003c\/li\u003e\n\u003cli\u003eDiagnosis of different types of diabetes\u003c\/li\u003e\n\u003cli\u003eUtilization of recent technology advances in diabetes care\u003c\/li\u003e\n\u003cli\u003eOptimizing care for people with obesity\u003c\/li\u003e\n\u003cli\u003eAssessing and treating cardiovascular and renal complications\u003c\/li\u003e\n\u003cli\u003eGuiding patients on physical activity and medical nutrition\u003c\/li\u003e\n\u003cli\u003eManagement of hypertension and dyslipidemia\u003c\/li\u003e\n\u003cli\u003eAddressing low engagement in therapy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eNEW DATA and PRACTICE GUIDELINES for DIABETES CARE\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe newest data on the identification of different types of diabetes\u003c\/li\u003e\n\u003cli\u003eThe latest scientific information on how to reduce cardiovascular and renal disease risk in patients with type 2 diabetes\u003c\/li\u003e\n\u003cli\u003eNew guidelines and practice recommendations for nutrition and physical activity coupled with instruction to incorporate them into your current approaches to diabetes care\u003c\/li\u003e\n\u003cli\u003eCriteria to navigate the controversial data related to some anti-diabetes medications\u003c\/li\u003e\n\u003cli\u003eMedical vs. surgical management of obesity\u003c\/li\u003e\n\u003cli\u003eNew technologies in diabetes care: updates and implications for day-to-day care\u003c\/li\u003e\n\u003cli\u003eResearch breakthroughs\u003c\/li\u003e\n\u003cli\u003eTips and tricks for navigating barriers within healthcare systems\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eASSESSMENT and TREATMENT of COMPLICATIONS from DIABETES\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThe 2024 program provides education to assess and treat:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCardiovascular Disease\u003c\/li\u003e\n\u003cli\u003eCongestive Heart Failure\u003c\/li\u003e\n\u003cli\u003eRenal Disease\u003c\/li\u003e\n\u003cli\u003eMetabolic-Associated Fatty Liver Disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eOPTIMIZING HEALTH OUTCOMES for DIVERSE PATIENT POPULATIONS\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis program also provides comprehensive guidance to account for biological, psychological, emotional, social, financial, and cultural factors that impact the development and progression of diabetes.\u003cbr\u003e\u003cbr\u003eCoverage includes:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRacial and ethnic minorities\u003c\/li\u003e\n\u003cli\u003eThe elderly\u003c\/li\u003e\n\u003cli\u003ePeople with obesity\u003c\/li\u003e\n\u003cli\u003ePatients at high cardiovascular risk\u003c\/li\u003e\n\u003cli\u003eIndividuals with low engagement in therapy\u003c\/li\u003e\n\u003cli\u003ePatients at low socio-economic levels\u003c\/li\u003e\n\u003cli\u003eSubjects with low health literacy\/education\u003c\/li\u003e\n\u003cli\u003eIndividuals with depression\/emotional distress\u003c\/li\u003e\n\u003cli\u003ePatients with metabolic liver disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003ch4\u003ePRACTICE IMPACT\u003c\/h4\u003e\u003cbr\u003eOver four days, you will gain new, encompassing, evidence-based approaches to address the challenges seen in most clinical practices. More importantly, you will leave with knowledge—part art, part science—to make a real difference in the lives of your patients.\u003cbr\u003e\u003ch4\u003eOPTIMIZED for REMOTE EDUCATION\u003c\/h4\u003e\u003cbr\u003eThe 2023 program has been enhanced for distance learning. In addition to being live streamed, all sessions will be recorded and made available to participants for online viewing for 60 days after the end of the course.\u003cbr\u003e\u003cbr\u003eAlong with recordings and course presentations, additional resources such as guidelines, recent articles and relevant patient education materials will also be available.\u003cbr\u003e\u003ch3\u003eSchedule\u003cbr\u003ePrint\u003c\/h3\u003e\u003cbr\u003eAll times listed below are Eastern Daylight Time\u003cbr\u003e\u003ch3 style=\"text-align: center;\"\u003e.\u003cbr\u003eWednesday, May 03, 2023\u003c\/h3\u003e\u003cbr\u003eWelcome and IntroductionA. Enrique Caballero, MD\u003cbr\u003e\u003ch4\u003eOpening Lecture\u003c\/h4\u003e\u003cbr\u003eDiabetes Report Card: How Are We Doing in Diabetes Care?A. Enrique Caballero, MD\u003cbr\u003e\u003ch4\u003eIdentifying Various Types of Diabetes in Clinical Practice\u003c\/h4\u003e\u003cbr\u003ePractical Approach to Identifying Different Types of Diabetes in Clinical PracticeLucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC\u003cbr\u003eCurrent Understanding of Diabetes PhenotypesMiriam Udler, MD, PhD\u003cbr\u003e\u003cbr\u003eQ \u0026amp; A and Clinical Cases DiscussionLucia Novak, MSN, ANP-BC, BC-ADM, CDTC and Miriam Udler, MD, PhD\u003cbr\u003e\u003ch4\u003eManagement of Diabetes in the Elderly\u003c\/h4\u003e\n\u003col\u003e\n\u003cli\u003eType 2 Diabetes in the Elderly: What You Need to KnowMedha Munshi, MD\u003c\/li\u003e\n\u003cli\u003eA Practical Approach to Anti-Diabetes Medication SelectionMarie McDonnell, MD\u003c\/li\u003e\n\u003cli\u003eQ \u0026amp; A and Clinical Cases DiscussionMedha Munshi, MD and Marie McDonnell, MD\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch4\u003eMedical Nutrition Management in Diabetes and Obesity\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eCurrent Nutrition Recommendations and GuidelinesLaura Andromalos, MS, RD, RN, CSOWM, CDCES\u003c\/li\u003e\n\u003cli\u003eThe Carbohydrate-Insulin Model: A Novel Approach to DiabesityDavid Ludwig, MD, PhD\u003c\/li\u003e\n\u003cli\u003e Q \u0026amp; A and Clinical Case DiscussionLaura Andromalos, MS, RD, CSOWM, CDCES and David Ludwig, MD, PhD\u003c\/li\u003e\n\u003cli\u003e Interactive Breakout Sessions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 style=\"text-align: center;\"\u003eThursday, May 04, 2023\u003c\/h3\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eWelcome, Recap of Day 1, and Description of Day 2 ActivitiesA. Enrique Caballero, MD\u003cbr\u003e\u003ch4\u003eSpecial Lecture\u003c\/h4\u003e\u003cbr\u003eNon-Alcoholic Fatty Liver DiseaseScott Isaacs, MD, FACP, FACE\u003cbr\u003e\u003ch4\u003ePrescribing Exercise to Patients with Diabetes\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eExercise in Diabetes Care: The Basics on What Works and WhyJane Reusch, MD\u003c\/li\u003e\n\u003cli\u003e Exercise Recommendations: Building a Tailored Program considering Diabetes Status and ComplicationsJacqueline Shahar, MEd, RCEP, CDCES\u003c\/li\u003e\n\u003cli\u003eQ \u0026amp; A and Clinical Case DiscussionJane Reusch, MD and Jacqueline Shahar, MEd, RCEP, CDCES\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eObesity Management: The Controversies\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacological Management: Individualizing TherapyW. Scott Butsch, MD, MSc\u003c\/li\u003e\n\u003cli\u003eSurgical Management: Why and When?Philip R. Schauer, MD\u003c\/li\u003e\n\u003cli\u003eQ \u0026amp; A and Clinical Cases DiscussionW. Scott Butsch, MD, MSc and Philip R. Schauer, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eDyslipidemia Management in the Patient with DM\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e Addressing LDL: Cholesterol as Primary TargetOm Ganda, MD\u003c\/li\u003e\n\u003cli\u003e Triglycerides and HDL: Cholesterol Management—When and How?Aruna Pradhan, MD, MPH\u003c\/li\u003e\n\u003cli\u003eQ \u0026amp; A and Clinical Case DiscussionOm Ganda,MD and Aruna Pradhan, MD, MPH\u003c\/li\u003e\n\u003cli\u003eInteractive Breakout Sessions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 style=\"text-align: center;\"\u003eFriday, May 05, 2023\u003c\/h3\u003e\u003cbr\u003eWelcome, Recap of Day 2 and Description of Day 3 ActivitiesA. Enrique Caballero, MD\u003cbr\u003e\u003ch4\u003eSpecial Lecture\u003c\/h4\u003e\u003cbr\u003eThe Microbiome in Obesity, Diabetes, and Related DisordersPatricia Davidson, DCN, RDN, LDN, CDCES, FAND, CHSE, FADCES\u003cbr\u003e\u003ch4\u003eHypertension Management in the Patient with Diabetes\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e Clinical Evaluation of the Patient with HypertensionNaomi Fisher, MD\u003c\/li\u003e\n\u003cli\u003eCurrent Recommendations for the Treatment of HypertensionJohn Forman, MD\u003c\/li\u003e\n\u003cli\u003eQ \u0026amp; A and Clinical Case DiscussionNaomi Fisher, MD and John Forman, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eCardiovascular Risk Reduction\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eEvaluation of CV Risk: Practical RecommendationsJorge Plutzky, MD\u003c\/li\u003e\n\u003cli\u003eReducing CV Risk in the Patient with Diabetes: A Comprehensive ApproachChristopher Cannon, MD\u003c\/li\u003e\n\u003cli\u003eQ \u0026amp; A and Clinical Case DiscussionJorge Plutzky, MD and Christopher Cannon, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eTechnology Advances in the Management of Diabetes\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eContinuous Glucose Monitoring: A 2023 VisionDevin Steenkamp, MD\u003c\/li\u003e\n\u003cli\u003eInsulin Pumps, Closing the Loop: Where Do We Stand?Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP\u003c\/li\u003e\n\u003cli\u003eQ \u0026amp; A and Clinical Cases DiscussionDevin Steenkamp, MD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP\u003c\/li\u003e\n\u003cli\u003eInteractive Breakout Sessions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 style=\"text-align: center;\"\u003eSaturday, May 06, 2023\u003c\/h3\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eWelcome, Recap of Day 3 and Description of Day 4 ActivitiesA. Enrique Caballero, MD\u003cbr\u003e\u003ch4\u003ePharmacological Management of Diabetes\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eTraditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)A. Enrique Caballero, MD\u003c\/li\u003e\n\u003cli\u003e Incretin-Based Therapies (DPP-IV Inhibitors and GLP-1 RA)Juan P. Frias, MD\u003c\/li\u003e\n\u003cli\u003e SGLT-2 InhibitorsSilvio Inzucchi, MD\u003c\/li\u003e\n\u003cli\u003eInsulin TherapyAnne L. Peters, MD\u003c\/li\u003e\n\u003cli\u003e Q \u0026amp; A and Clinical Cases DiscussionA. Enrique Caballero, MD, Juan P. Frias, MD, Silvio Inzucchi, MD, and Anne L. Peters, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eAddressing Diversity in Diabetes Care\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eHow Do Race and Ethnicity Influence Diabetes Management Decisions?A. Enrique Caballero, MD\u003c\/li\u003e\n\u003cli\u003eIdentifying Community-Based Resources to Help Patients with DiabetesJosh Trautwein\u003c\/li\u003e\n\u003cli\u003eQ \u0026amp; A Clinical Cases DiscussionA. Enrique Caballero, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eKeynote Lecture\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eThe Road towards Equity in Diabetes CareJanet Brown-Friday, RN, MSN, MPH\u003c\/li\u003e\n\u003cli\u003e Interactive Breakout Sessions\u003c\/li\u003e\n\u003cli\u003eClosing RemarksA. Enrique Caballero, MD\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954287251554,"sku":"MED-AMB00298","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-Medical-School-Diabetes-Update-2023.jpg?v=1779370056","url":"https:\/\/meducourse.com\/products\/harvard-medical-school-diabetes","provider":"Meducourse","version":"1.0","type":"link"}